|
Type
2 Diabetes: Treatment Options
Please
read the following information and select the appropriate link
at the bottom of the page to continue.
Target
Audience: Pharmacists, nurses, dietitians, and nurse
practitioners who are involved with patient education and counseling.
Goal:
To provide information on various treatment options
for individuals with type 2 diabetes
Educational
Objectives: Upon completion of this activity participants
should be able to:
- Describe
the pathophysiology of type 2 diabetes
- State
special considerations, benefits, and risks of three classes
of oral antidiabetic drugs (OADs)
- Describe
the benefits of insulin therapy in patients with type 2 diabetes
To
receive a statement of credit, you must:
- Successfully
complete the post-test (70% or better).
- Complete
the program evaluation.
Your statement
of credit will be issued immediately upon successful completion
of the test and submission of the evaluation form. The statement
of credit specific to your discipline will appear on your screen
and you will be given the option to print it for your files.
No additional statement of credit will be issued.
Activity
Presenter:
 Virginia
Peragallo-Dittko, RN, BC-ADM, MA, CDE
Director of the Diabetes Education Center
Winthrop-University Hospital
Mineola, New York
The
following program is a presentation by Virginia Peragallo-Dittko.
Ms. Peragallo-Dittko is the Director of the Diabetes Education
Center at Winthrop-University Hospital in Mineola, New York.
She has been a diabetes nurse-specialist in a variety of settings
since 1979. She was named Diabetes Educator of the Year by the
American Association of Diabetes Educators and has been a member
of the Editorial Board of The Diabetes Educator journal.
Ms. Peragallo-Dittko is the editor of the textbook, A Core
Curriculum for Diabetes Education, second edition and Addendum.
She serves as Editor-in-Chief of Program Publications for the
American Diabetes Association. She has published in the area
of diabetes education in books as well as lay and professional
journals. Ms. Peragallo-Dittko has lectured extensively for
both lay and professional audiences and has participated in
both radio and television interviews.
Fee:
There is no fee to receive credits for this program.
Commercial
Supporter: This program has been supported through
an unrestricted educational grant from Novo Nordisk Pharmaceuticals,
Inc.
Trademarks:
Diabinese,
Glucotrol, and Glucotrol XL are registered trademarks of Pfizer,
Inc.
Orinase, Tolinase, Micronase, and Glynase are registered trademarks
of Pharmacia Corporation.
Glyset is a registered trademark of Bayer Corporation, licensed
to Pharmacia Corporation.
Diabeta and Amaryl are registered trademarks of Hoechst Marion
Roussel, Division of Aventis Pharmaceuticals.
Actos is a registered trademark of Takeda Pharmaceuticals America,
Inc.
Avandia is a registered trademark of GlaxoSmithKline.
Avandamet is a trademark of GlaxoSmithKline.
Precose is a registered trademark of Bayer Corporation.
Glucophage, Glucophage XR, and Glucovance are registered trademarks
of Merck Sante S.A.S., licensed to Bristol-Myers Squibb Company.
Metaglip is a trademark of Merck Sante S.A.S., licensed to Bristol-Myers
Squibb Company.
Starlix is a registered trademark of Novartis Pharmaceuticals
Corporation.
Novolin, NovoLog, Lente, Ultralente, Velosulin, and Prandin
are registered trademarks of Novo Nordisk A/S.
Humalog, Humulin are registered trademarks of Eli Lilly and
Company.
Lantus is a registered trademark of Aventis Pharmaceuticals.
Disclosure
Declaration: It
is the policy of Novo Nordisk Pharmaceuticals, Inc. and the
American Association of Diabetes Educators to ensure independence,
balance, objectivity, scientific rigor, and integrity in all
of their continuing education activities. The faculty must disclose
to the participants any significant relationships with the commercial
companies whose products or devices may be mentioned in the
activity or with the supporter of this continuing education
activity. The information is for participant information; it
is not assumed that these relationships will have a negative
impact on the content of the activity.
Ms. Peragallo-Dittko
has disclosed that she has received an honorarium for narrating
this activity.
Disclaimers:
- Approval
of credit for this continuing education program does not imply
endorsement by AADE of any product or manufacturer identified.
- Any medications
or treatment methods suggested in this CE activity should
not be used by the practitioner without evaluation of their
patient's condition(s) and possible contraindication(s) or
danger(s) of use of any specific medication.
- This
activity may include discussions of products or devices that
are not currently approved for use by the Food and Drug Administration
(FDA).
- Novo
Nordisk Pharmaceuticals, Inc., the American Association of
Diabetes Educators, and the activity's faculty do not endorse
the use of any product in a manner that is not approved by
the FDA.
The author, sponsor, and publisher of this continuing education
program have made all reasonable efforts to ensure that information
contained herein is accurate in accordance with the latest
available scientific knowledge at the time of accreditation
of this continuing education program. Information regarding
drugs (e.g., their administration, dosages, contraindications,
adverse reactions, interactions, special warnings, precautions)
and drug delivery systems is subject to change, however, and
the reader is advised to check the manufacturer's package
insert for information concerning recommended dosage and potential
problems or cautions prior to dispensing or administering
the drug or using the drug delivery systems.
Click
the appropriate profession to continue to the activity:
Pharmacists
click here
Nurses
click here
Dietitians
click here
Nurse
Practitioners click here
Other
Healthcare Professionals click here
Copyright
© 2003 Novo Nordisk Pharmaceuticals, Inc. All rights reserved.
126206
For our Terms of Use and Privacy Policy, please review our Legal
Agreement.
Copyright© 2004 CECity® All rights reserved.
|
Supported
through an unrestricted educational grant 
